| Literature DB >> 35890716 |
Xuan Yan1, Haiyan Yao2,3,4, Jun Luo1,3,4, Zhihua Li1,3,4, Junchao Wei1,2,3,4.
Abstract
Bone-tissue engineering is an alternative treatment for bone defects with great potential in which scaffold is a critical factor to determine the effect of bone regeneration. Electrospun nanofibers are widely used as scaffolds in the biomedical field for their similarity with the structure of the extracellular matrix (ECM). Their unique characteristics are: larger surface areas, porosity and processability; these make them ideal candidates for bone-tissue engineering. This review briefly introduces bone-tissue engineering and summarizes the materials and methods for electrospining. More importantly, how to functionalize electrospun nanofibers to make them more conducive for bone regeneration is highlighted. Finally, the existing deficiencies of functionalized electrospun nanofibers for promoting osteogenesis are proposed. Such a summary can lay the foundation for the clinical practice of functionalized electrospun nanofibers.Entities:
Keywords: bone regeneration; bone-tissue engineering; electrospun nanofiber; functionalization; scaffold
Year: 2022 PMID: 35890716 PMCID: PMC9318783 DOI: 10.3390/polym14142940
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.967
Figure 1(A) Schematic of classical electrospinning setup. Reproduced with permission from [7]. Copyright Wiley 2021; (B) Schematic of blended electrospinning setup. Reproduced with permission from [73]. Copyright Remaking Singapore Committee 2019; (C) Schematic of multi-axial electrospinning setup. Reproduced with permission from [74]. Copyright Wiley 2020; (D) Schematic of coaxial electrospinning setup. Reproduced with permission from [76]. Copyright 2019, Elsevier.
Figure 2(A) Fabrication and application of the nanofiber scaffolds with SF and HAp coating; (B) Micro-CT images of the defect areas for 4 and 12 weeks. Reproduced with permission from [86]. Copyright 2021, Elsevier.
Figure 3(A) Schematic of fabrication of the artificial scaffold with biofunction through LbL self-assembly. Reproduced with permission from [87]. Copyright 2021, Elsevier; (B) Schematic of preparation of the SF/PCL/PVA coaxial fibers with BMP-2 and CTGF via LbL for BTE. Reproduced with permission from [89]. Copyright American Chemical Society 2019; (C) Schemes of fabricating tissue-engineered periosteum (TEP) and application for bone defects. Reproduced with permission from [90]. Copyright 2018, Elsevier.
Figure 4(A) Proliferation of MSCs on different scaffolds cultured for 7 days; (B) Alkaline phosphatase (ALP) activity in 2 weeks; (C) Alizarin red staining of MSCs on different scaffolds cultured in osteogenic culture medium for 14 days, * p ≤ 0.05, *** p ≤ 0.001. Reproduced with permission from [97]. Copyright Wiley 2018.
Figure 5(A) (a) Schematic diagram of chemical structure of grafted polymer OA-PLL-PEG-N3 graft polymer; (b) Schematic of synthesis process about dibenzocyclooctyne-modified BMP-2 nanocapsules; (c) Schematic of surface functionalization on the surface of PCL scaffold for controlling the release of growth factor; (B) Illustration of Alizarin Red Staining results of BMSCs for 10 days; (C) Illustration of the ALP staining results of BMSCs. Reproduced with permission from [101]. Copyright Frontiers 2022.
Figure 6(A) Schematic of activated electrospun PCL nanofibers immobilized with anti-BMP-2 and anti-VEGF; (B) Schematic of vascularization in bone defect area. Reproduced with permission from [103]. Copyright Remaking Singapore Committee.